Raymond L, Bulliard J L, Levi F, Enderlin F, Méan A, Schüler G, Torhorst J
Geneva Cancer Registry, Switzerland.
Eur J Cancer. 1994;30A(7):978-82. doi: 10.1016/0959-8049(94)90127-9.
Estimates have recently been made of the incidence of cancers in the countries of the European Community. Similar estimates are given for Switzerland, based on data from the six Swiss cantonal cancer registries, all of which have been operating for at least 12 years. These registries cover Basel, Geneva, Neuchatel, St Gall and Appenzell, Vaud and Zurich, which account for about 50% of the Swiss population as a whole. Two different methods were used to extrapolate from the incidences observed in the regions covered by cancer registration to the entire country. The first method is based solely on the distribution of populations according to the country's main linguistic groups, whereas the second relies on mortality data. Estimates obtained by the second approach are presented and their reliability is discussed. Comparison of the age incidence curve with that of Denmark tends to confirm the validity of the estimations. Estimated standardised rates (world population) for all sites except nonmelanomatous skin cancer are 294.3 for males and 214.2 for females. Comparisons with other European countries show that in males, lung cancer is relatively less common in Switzerland, whereas in females, breast cancer is relatively more frequent.
最近有人对欧洲共同体国家的癌症发病率进行了估算。基于瑞士六个州癌症登记处的数据,也给出了瑞士的类似估算值,这些登记处均已运营至少12年。这些登记处覆盖巴塞尔、日内瓦、纳沙泰尔、圣加仑、阿彭策尔、沃州和苏黎世,这些地区的人口约占瑞士总人口的50%。采用了两种不同的方法,将癌症登记所覆盖地区观察到的发病率推算至整个国家。第一种方法仅基于该国主要语言群体的人口分布,而第二种方法则依赖于死亡率数据。给出了通过第二种方法获得的估算值,并讨论了其可靠性。将年龄发病率曲线与丹麦的曲线进行比较,倾向于证实这些估算的有效性。除非黑色素瘤皮肤癌外,所有部位的估计标准化率(世界人口)男性为294.3,女性为214.2。与其他欧洲国家的比较表明,在男性中,肺癌在瑞士相对不那么常见,而在女性中,乳腺癌相对更常见。